Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial ...Middle East

BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the successful completion of dosing of the...

Hence then, the article about tessa therapeutics announces successful dosing of first patient cohort in phase i allogeneic cell therapy trial was published today ( Wednesday 10/02/2021 - 02:31 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial )

Also on site :

• Meta Removes Muse Image AI Feature After Backlash: “Missed The Mark”
• JD Vance Brags About His Cushy Life as Americans Struggle to Buy Food
• Walmart's 'Sleek' $54 Metal-Frame Sling Chair Gives Your Home West Elm Vibes for a Fraction of the Price